Abstract
A new integrated optical and electrochemical sensor system for simultaneous monitoring of intra- and extracellular superoxide (O2-) was developed using an array-based cell chip. For in vitro assays, A172 human glioblastoma cells were transferred into the cell chip and stimulated by phorbol 12-myristate 13-acetate (PMA). Intracellular O2- generation was detected via fluorescence image analysis with a dye probe, dihydrorhodamine 123 (DHR 123). Extracellular O2- was detected using an amperometric sensor constructed by immobilisation of cytochrome c using a binder, 3,3′-dithiobis(sulphosuccinimidylpropionate), to attach the redox protein onto the surface of electrodeposited Au electrodes incorporated into the optically transparent cell chip. The simultaneous intra- and extracellular production of O2- was successfully observed from PMA-stimulated A172 cells and inhibited by superoxide dismutase (SOD). The quantification of O2- concentration based on a mathematical model study and possible applications using the sensor system developed were discussed. The results confirm that there was no detectable interference or crosstalk between the optical and electrochemical assays. Feasibility of the integration of the two methods, optical and electrochemical, and the neutralisation of the intra- and extracellular O2- levels by SOD have been demonstrated.
Original language | English |
---|---|
Pages (from-to) | 979-984 |
Number of pages | 6 |
Journal | Biochemical and Biophysical Research Communications |
Volume | 327 |
Issue number | 4 |
DOIs | |
State | Published - 25 Feb 2005 |
Bibliographical note
Funding Information:This study is funded by and is a part of the EC project, ‘Novel in vitro testing platforms based on intra- and extracellular sensing: CellSens’ (No. QLRT-2001-00244), and also by the Horowitz foundation. The authors are grateful to Dr. Mike Jackson (CRL, UK) for the design and manufacture of the array sensor platforms.
Funding
This study is funded by and is a part of the EC project, ‘Novel in vitro testing platforms based on intra- and extracellular sensing: CellSens’ (No. QLRT-2001-00244), and also by the Horowitz foundation. The authors are grateful to Dr. Mike Jackson (CRL, UK) for the design and manufacture of the array sensor platforms.
Funders | Funder number |
---|---|
Horowitz Foundation for Social Policy | |
European Commission | QLRT-2001-00244 |
Keywords
- A172 glioblastoma
- Amperometric
- Array sensor
- DHR 123
- In vitro
- Optico-electrochemical device
- Simultaneous
- Superoxide